Generated by All in One SEO v4.9.0, this is an llms.txt file, used by LLMs to index the site.

# Kelso Pharma

A growing specialty pharma business​

## Sitemaps

- [XML Sitemap](https://kelsopharma.com/sitemap.xml): Contains all public & indexable URLs for this website.

## Posts

- [ALTURiX presents new research which highlights the challenges in accessing and managing epilepsy rescue medicines](https://kelsopharma.com/alturix-presents-new-research-which-highlights-the-challenges-in-accessing-and-managing-epilepsy-rescue-medicines/) - ALTURiX, part of the Kelso Pharma Group, will be presenting new research at the International League Against Epilepsy (ILAE) British Branch Annual Scientific Conference, beginning tomorrow (8th October 2026), highlighting the significant challenges faced by people living with epilepsy and healthcare professionals when managing rescue medications. Two studies, supported and commissioned by ALTURiX, provide new
- [Kelso Pharma prepares for further European growth as Velit Biopharma rebrands as Kelso Pharma Italy](https://kelsopharma.com/kelso-pharma-prepares-for-further-european-growth-as-velit-biopharma-rebrands-as-kelso-pharma-italy/) - Kelso Pharma, the high-growth specialty pharmaceuticals business, announces that Italian-based Velit Biopharma, acquired in November 2023, will trade as ‘Kelso Pharma Italy’ from today (21 October 2025), as the business gears up for further growth across European markets. The rebranding of Velit Biopharma to Kelso Pharma Italy is a natural next step in the growth
- [Kelso Pharma team returns to Edinburgh for annual all-company meeting](https://kelsopharma.com/kelso-pharma-team-returns-to-edinburgh-for-annual-all-company-meeting/) - Last week, the Kelso Pharma team travelled to Edinburgh for our annual all-company meeting. As the business continues to grow at pace, so does our team, with lots of energy in the room during our time together. It was fantastic being able to welcome everyone to Scotland and enjoy a couple of days of engaging
- [Kelso Pharma appoints new CFO](https://kelsopharma.com/kelso-pharma-appoints-new-cfo/) - Kelso Pharma, the high-growth specialty pharmaceuticals business, announces that Allan Watson, the company’s Chief Financial Officer, has decided to retire from his role and is being succeeded by life sciences financial specialist, Alan King. Apposite Capital-backed Kelso Pharma is focused on bringing innovative, value-added, specialty medicines to international healthcare markets, providing products that improve the
- [Kelso Pharma builds for future growth with appointment of life sciences leader as Chief Operating Officer](https://kelsopharma.com/kelso-pharma-builds-for-future-growth-with-appointment-of-life-sciences-leader-as-chief-operating-officer/) - Kelso Pharma, the growing UK-based specialty pharmaceuticals business, has appointed life sciences leader, Dr. Bee Koen Low, as its first Chief Operating Officer. With over 20 years’ experience in the pharmaceutical industry, Bee brings extensive scientific expertise and understanding of the sector to the role, including in the key areas of: M&A due diligence and
- [Kelso Pharma secures £140m of acquisition funding and appoints senior pharma executive as Non-Executive Director](https://kelsopharma.com/kelso-pharma-secures-140m-of-acquisition-funding-and-appoints-senior-pharma-executive-as-non-executive-director/) - Kelso Pharma, the growing specialty pharma business backed by Apposite Capital, the healthcare specialist private equity investor, announces that it has secured over £140 million of acquisition funding and appointed former ADVANZ PHARMA CEO, Graeme Duncan, as Non-Executive Director. A proportion of the funding was used by Kelso Pharma in its acquisition of ALTURiX last
- [Kelso Pharma’s European growth story continues with appointment of new General Manager in Italy](https://kelsopharma.com/kelso-pharmas-european-growth-story-continues-with-appointment-of-new-general-manager-in-italy/) - Kelso Pharma, the growing UK based specialty pharmaceuticals business, has appointed experienced pharma executive, Giovanni Mauri, as General Manager at Velit Biopharma, the Italian-based pharma business that was acquired by Kelso Pharma in November 2023. With a wealth of experience across a variety of key markets in the life sciences sector, Giovanni Mauri specialises in
- [Kelso Pharma acquires UK pharma business, ALTURiX](https://kelsopharma.com/kelso-pharma-acquires-uk-pharma-business-alturix/) - Kelso Pharma, the growing specialty pharma business backed by Apposite Capital, the healthcare specialist private equity investor, today (19 February 2025) announces the acquisition of the UK pharma business, ALTURiX Holdings Limited (ALTURiX). The transaction marks a significant step towards Kelso’s vision of building a specialty pharma business of scale in the UK and ultimately
- [Kelso Pharma Group gather in Edinburgh for All Company meeting](https://kelsopharma.com/kelso-pharma-group-gather-in-edinburgh-for-all-company-meeting/) - Last week, members of the Kelso Pharma Group from across the globe travelled to Scotland’s capital, Edinburgh, for an insightful and engaging all company meeting. With presentations from Kelso Pharma board members and senior management as well as break out sessions, it offered the opportunity for Kelso Pharma, Stirling Anglian Pharmaceuticals and Velit Biopharma teams
- [Kelso Pharma appoints first Director of Corporate Development as international expansion continues](https://kelsopharma.com/kelso-pharma-appoints-first-director-of-corporate-development-as-international-expansion-continues/) - Kelso Pharma, the growing UK based specialty pharmaceuticals business, has appointed experienced pharma executive, John Rooper, as Director of Corporate Development as the company eyes further growth across international markets. With a wealth of experience in the life sciences sector after working at Ernst and Young (EY) in a senior Mergers and Acquisitions (M&A) role
- [Stirling Anglian Pharmaceuticals launches new website with focus on providing patients with value-based solutions to healthcare](https://kelsopharma.com/stirling-anglian-pharmaceuticals-launches-new-website-with-focus-on-providing-patients-with-value-based-solutions-to-healthcare/) - Stirling Anglian Pharmaceuticals (SAP), part of the Kelso Pharma Group, has launched its brand-new website, focusing on their products, corporate responsibility and plans for sustainability moving forward. SAP is a UK based pharmaceutical company, part of the Kelso Pharma Group, with a purpose of bringing innovative, value added, specialty branded medicines to patients across the
- [Kelso Pharma closes acquisition of Italian specialty pharma company, Velit Biopharma](https://kelsopharma.com/kelso-pharma-closes-acquisition-of-italian-specialty-pharma-company-velit-biopharma/) - The acquisition of Italian specialty pharma company, Velit Biopharma (Velit), by UK-based specialty pharma business, Kelso Pharma (Kelso), announced on 13th November 2023, has now closed. This is the first step for Kelso in its European expansion strategy and Velit is now part of the Kelso group of companies, which also includes Glasgow-based Stirling Anglian
- [Kelso Pharma announces strategic partnerships with PharmaPath and Valpharma](https://kelsopharma.com/kelso-pharma-announces-strategic-partnerships-with-pharmapath-and-valpharma/) - Kelso Pharma, the growing UK-based specialty pharma business, has concluded two new collaboration agreements with pharmaceuticals companies, PharmaPath and Valpharma. The specific products are not being disclosed at this time but the partnerships will add a new therapeutic area to the product portfolio of Kelso Pharma and its UK subsidiary, Stirling Anglian Pharmaceuticals (SAP). PharmaPath,
- [Kelso Pharma initiates European expansion with acquisition of Italian specialty pharma company, Velit Biopharma](https://kelsopharma.com/kelso-pharma-initiates-european-expansion-with-acquisition-of-italian-specialty-pharma-company-velit-biopharma/) - Kelso Pharma (Kelso), the growing UK-based specialty pharma business, has taken its first step in its European expansion strategy by agreeing to acquire Italian specialty pharma company, Velit Biopharma (Velit). With more than 100 partnership agreements in place with pharma companies in Europe, Asia and the Middle East, Velit has a portfolio of more than
- [Kelso Pharma announces two UK product acquisitions as growth continues](https://kelsopharma.com/kelso-pharma-announces-two-uk-product-acquisitions-as-growth-continues/) - Kelso Pharma, the growing UK-based specialty pharma business, has concluded a deal to acquire two UK approved products, representing an exciting launch into the specialty of Dermatology with prescription medicines for the treatment of actinic keratoses and plaque psoriasis. The two dermatology products, purchased from an organisation within the Dermapharm Group, represent another exciting move
- [Kelso Pharma at home in Scotland’s capital](https://kelsopharma.com/kelso-pharma-at-home-in-scotlands-capital/) - The Kelso Pharma team announces the establishment of its first office space in Edinburgh, Scotland.
- [<strong>Kelso Pharma announces first product launch</strong>](https://kelsopharma.com/kelso-pharma-announces-first-product-launch/) - Kelso Pharma, the growing UK based specialty pharma business, has announced its first product launch with the release to the UK prescription medicines market of Acepiro® (Acetylcysteine) 600mg effervescent tablets. Acepiro (Acetylcysteine) is indicated in adults as a mucolytic agent for the treatment of respiratory tract diseases in which a reduction in bronchial secretion viscosity
- [Kelso Pharma appoints UK Managing Director](https://kelsopharma.com/kelso-pharma-appoints-uk-managing-director/) - Kelso Pharma, the growing UK based specialty pharma business, has appointed senior pharmaceutical executive, Mark Inker, as its first UK Managing Director. A pharmaceutical company director with over 30 years’ experience in commercialisation of pharmaceutical and medical device products, Mark has built a strong track record for growing businesses in the sector. His mix of
- [Kelso Pharma appoints Life Sciences leader as Chairman](https://kelsopharma.com/kelso-pharma-appoints-life-sciences-leader-as-chairman/) - Kelso Pharma, the growing specialty pharma business, has appointed senior Life Sciences executive, Gordon Cameron OBE, as its Non-Executive Chairman.
- [Kelso Pharma CEO featured in The Scotsman Scotland on Sunday ‘Business Big Interview’](https://kelsopharma.com/kelso-pharma-ceo-featured-in-the-scotsman-scotland-on-sunday-business-big-interview/) - Kelso Pharma CEO, Dr. Tom Stratford, was recently featured in The Scotsman Scotland on Sunday ‘Business Big Interview’. Tom discusses his early career, his entrepreneurial motivations, and what the future holds for Kelso Pharma. You can read the full interview with Tom here.
- [Apposite Capital-backed Kelso Pharma acquires Stirling Anglian Pharmaceuticals](https://kelsopharma.com/apposite-capital-backed-kelso-pharma-acquires-stirling-anglian-pharmaceuticals/) - Apposite Capital, the healthcare specialist private equity investor, and Kelso Pharma today announce the acquisition of Stirling Anglian Pharmaceuticals Limited. Kelso Pharma is headed by Dr Tom Stratford, previously CEO of Kyowa Kirin International (“KKI”), the European and US business arm of Kyowa Kirin, which purchased Scottish Borders based ProStrakan Group PLC in 2011. He

## Pages

- [Home](https://kelsopharma.com/) - At Kelso Pharma, our vision is to bring innovative, value added, specialty medicines to the European healthcare markets.
- [Anti-Bribery and Corruption Policy](https://kelsopharma.com/anti-bribery-and-corruption-policy/) - Anti-Bribery and Corruption Policy Last updated: 27/03/2025 We Put Patients First and Do the Right Thing Bribery and corruption can happen anywhere and in any company. We must be aware of the risk of bribery and corruption not only when we sell and market our products, but also when we conduct all other areas of
- [Privacy Policy](https://kelsopharma.com/privacy-policy/) - Kelso Pharma (“Company“, “we“, “us“, “our“) are committed to protecting your personal information and your right to privacy.
- [Kelso Pharma Italy](https://kelsopharma.com/kelso-pharma-italy/) - Kelso Pharma Italy is committed to expanding the reach of Kelso Pharma Group medicines through partnerships with select pharmaceutical companies. The company specialises in developing and supplying specialty, ‘hard-to-make’ medicines, which are made available to patients through licensees across Europe and beyond. Kelso Pharma Italy has over 100 active partnerships and more than 80 granted
- [News](https://kelsopharma.com/news/) - At Kelso Pharma, our vision is to bring innovative, value added, specialty medicines to the European healthcare markets. Medicines that provide meaningful benefits to patients and create added value for healthcare stakeholders.
- [Cookies](https://kelsopharma.com/cookies/) - Kelso Pharma (“Company“, “we“, “us“, “our“) may use cookies when you visit our website, including any other media form, media channel, mobile website

## JetPopup

- [Group](https://kelsopharma.com/jet-popup/group/) - The Kelso Pharma Group We bring innovative, value added, specialty medicines through a blend of company & product acquisitions, partnerships and organic growth, both in the UK and in Europe. Our Group

## My Templates

- [Elementor Header #1175](https://kelsopharma.com/?elementor_library=elementor-header-1175) - Linkedin-in X-twitter
- [Elementor Footer #690](https://kelsopharma.com/?elementor_library=elementor-footer-690)
- [Elementor Header #2057](https://kelsopharma.com/?elementor_library=elementor-header-2057) - Linkedin-in Twitter Our group
- [Elementor Header #1900](https://kelsopharma.com/?elementor_library=elementor-header-1900) - Linkedin-in Twitter
- [Elementor Single Post #1699](https://kelsopharma.com/?elementor_library=elementor-single-post-1699) - Share on facebook Share on twitter Share on linkedin Share on email Related News Read more Read more Read more
- [Default Kit](https://kelsopharma.com/?elementor_library=default-kit)
- [Maintenance](https://kelsopharma.com/?elementor_library=maintenance) - Under Construction

## Categories

- [Uncategorized](https://kelsopharma.com/category/uncategorized/)
- [Latest News](https://kelsopharma.com/category/latest-news/)

## Tags

- [John Rooper](https://kelsopharma.com/tag/john-rooper/)
- [Corporate Development](https://kelsopharma.com/tag/corporate-development/)
- [Kelso Pharma](https://kelsopharma.com/tag/kelso-pharma/)